Synthetic Biologics Inc. (SYN) is primed for evolution with the beta value of 2.23

For the readers interested in the stock health of Synthetic Biologics Inc. (SYN). It is currently valued at $0.65. When the transactions were called off in the previous session, Stock hit the highs of $0.69, after setting-off with the price of $0.65. Company’s stock value dipped to $0.62 during the trading on the day. When the trading was stopped its value was $0.60.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now.

Recently in News on December 22, 2020, Synthetic Biologics Announces Washington University School of Medicine in St. Louis IRB Approval of the SYN-004 (ribaxamase) Phase 1b/2a Clinical Protocol. IRB Approval Signals Phase 1b/2a Clinical Trial in Allogeneic HCT Recipients May Proceed as Planned; Enrollment Anticipated to Commence During Q1 2021. You can read further details here


A Backdoor Way To Profit From Today’s Crypto Bull Market

Even if you’re not actively in crypto, you deserve to know what’s actually going on...

Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.

Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .

Sponsored


Synthetic Biologics Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $1.7000 on 01/05/21, with the lowest value was $0.3830 for the same time period, recorded on 01/04/21.

Synthetic Biologics Inc. (SYN) full year performance was 29.33%

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Synthetic Biologics Inc. shares are logging -61.51% during the 52-week period from high price, and 159.44% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.25 and $1.70.

The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 17640356 for the day, which was evidently higher, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the Synthetic Biologics Inc. (SYN) recorded performance in the market was 70.84%, having the revenues showcasing 99.48% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 14.28M, as it employees total of 11 workers.

Analysts verdict on Synthetic Biologics Inc. (SYN)

During the last month, 1 analysts gave the Synthetic Biologics Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 1 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.

According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 0.4222, with a change in the price was noted +0.1442. In a similar fashion, Synthetic Biologics Inc. posted a movement of +28.27% for the period of last 100 days, recording 5,472,396 in trading volumes.

Synthetic Biologics Inc. (SYN): Technical Analysis

Raw Stochastic average of Synthetic Biologics Inc. in the period of last 50 days is set at 26.19%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 24.22%. In the last 20 days, the company’s Stochastic %K was 23.17% and its Stochastic %D was recorded 29.34%.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now.

Let’s take a glance in the erstwhile performances of Synthetic Biologics Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 70.84%. Additionally, trading for the stock in the period of the last six months notably improved by 25.68%, alongside a boost of 29.33% for the period of the last 12 months. The shares increased approximately by 30.83% in the 7-day charts and went down by 68.81% in the period of the last 30 days. Common stock shares were driven by 99.48% during last recorded quarter.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

LEAVE A REPLY

Please enter your comment!
Please enter your name here